Heart Condition Doctors Often Miss Is More Common Than You Think

Health Points

• ATTR-CM is a progressive heart condition caused by abnormal protein deposits that stiffen the heart, making it difficult to pump blood efficiently
• Common symptoms include shortness of breath, fatigue, and swelling in the legs, but these are often mistaken for normal aging or other heart conditions
• Early detection through specialized testing can significantly improve treatment outcomes and quality of life for patients over 60

A serious heart condition affecting thousands of Americans each year often goes undiagnosed for months or even years. Transthyretin amyloid cardiomyopathy, known as ATTR-CM, develops when misfolded proteins accumulate in the heart muscle, causing it to thicken and stiffen.

The condition primarily affects people over 60, yet many doctors don’t recognize the warning signs. These symptoms frequently mimic other common conditions, leading to delayed diagnosis and treatment.

Understanding the early warning signs could make the difference between timely intervention and irreversible heart damage. Here’s what every adult should know about this often-overlooked cardiac condition.

What Happens When Proteins Attack Your Heart

ATTR-CM occurs when a protein called transthyretin breaks apart and forms deposits in the heart tissue. These abnormal protein clumps, called amyloid fibrils, gradually build up in the heart walls.

Over time, these deposits make the heart muscle rigid and unable to relax properly between beats. The stiffened heart can’t fill with blood efficiently, reducing the amount of oxygen-rich blood pumped to the body.

There are two types of ATTR-CM: hereditary, caused by a genetic mutation passed down through families, and wild-type, which develops with age. Wild-type ATTR-CM is more common and typically appears after age 60, affecting men more frequently than women.

The Symptoms Doctors Mistake for Aging

The most common symptom of ATTR-CM is shortness of breath, especially during physical activity. Many patients dismiss this as simply being out of shape or a natural part of getting older.

Persistent fatigue and lack of energy represent another hallmark sign. Patients often feel exhausted even after routine activities that previously caused no problems.

Swelling in the lower legs, ankles, and feet occurs when the weakened heart can’t pump blood effectively, causing fluid to accumulate in the extremities. This swelling typically worsens throughout the day.

Some patients experience lightheadedness or dizziness, particularly when standing up. This happens because the stiff heart struggles to adjust blood flow quickly enough when changing positions.

The Warning Signs Beyond Your Chest

ATTR-CM doesn’t only affect the heart. Many patients develop carpal tunnel syndrome years before their heart condition is diagnosed.

Numbness or tingling in the hands and fingers occurs when amyloid deposits compress the median nerve in the wrist. Men who develop bilateral carpal tunnel syndrome after age 50 should be evaluated for ATTR-CM.

Spinal stenosis, a narrowing of the spaces in the spine, also appears more frequently in people with ATTR-CM. The condition can cause back pain and leg weakness.

Unexplained weight loss may signal that the body isn’t getting adequate nutrients due to poor blood circulation. Some patients also experience gastrointestinal symptoms like early fullness, nausea, or changes in bowel habits.

Why This Condition Flies Under the Radar

The symptoms of ATTR-CM overlap significantly with more common conditions like heart failure, high blood pressure, and coronary artery disease. Many patients receive treatments for these other conditions without improvement.

Medical education about ATTR-CM has been limited until recently. Many physicians simply aren’t trained to recognize the specific pattern of symptoms that suggest amyloid deposits.

Diagnosis requires specialized testing that isn’t part of routine cardiac evaluations. Standard heart tests like electrocardiograms and echocardiograms may show abnormalities, but they don’t definitively identify ATTR-CM.

The condition was once considered rare, so doctors didn’t actively look for it. Recent research suggests ATTR-CM is far more common than previously believed, affecting up to 13% of older adults with heart failure.

How Doctors Confirm the Diagnosis

When ATTR-CM is suspected, doctors use several specialized tests to confirm the diagnosis. Cardiac imaging with echocardiography or cardiac MRI can reveal the characteristic thickening and stiffening of the heart walls.

Nuclear imaging scans using radioactive tracers can detect amyloid deposits in the heart. These bone scans light up when amyloid protein is present, providing strong evidence of ATTR-CM.

Blood and urine tests help rule out other types of amyloidosis. Genetic testing determines whether a patient has hereditary or wild-type ATTR-CM.

In some cases, doctors perform a heart biopsy to examine tissue under a microscope. Special staining techniques can identify the specific type of amyloid protein present.

Treatment Options That Can Slow Progression

While there’s no cure for ATTR-CM, several treatments can slow disease progression and improve quality of life. New medications have been approved in recent years that stabilize the transthyretin protein and prevent it from breaking apart.

These stabilizer drugs can significantly slow the accumulation of new amyloid deposits in the heart. Patients who start treatment early often maintain better heart function for longer periods.

Gene-silencing therapies represent another treatment approach for hereditary ATTR-CM. These medications reduce the liver’s production of abnormal transthyretin protein.

Managing heart failure symptoms remains important even with specific ATTR-CM treatments. Doctors may prescribe diuretics to reduce fluid buildup, though many standard heart failure medications must be used cautiously in ATTR-CM patients.

Who Should Be Screened

Certain groups face higher risk for ATTR-CM and should discuss screening with their doctors. Men over 60 with unexplained heart failure represent a key group.

Anyone with a family history of ATTR-CM or unexplained heart disease should consider genetic testing. The hereditary form can appear at younger ages, sometimes in the 40s or 50s.

People of African descent have higher rates of a specific genetic variant that increases ATTR-CM risk. About 3-4% of African Americans carry this mutation.

Patients with thickened heart walls found on imaging studies without a clear cause need further evaluation. When unexplained carpal tunnel syndrome or spinal stenosis occurs alongside heart symptoms, screening becomes even more important.

The Importance of Early Detection

Catching ATTR-CM early makes a substantial difference in outcomes. Patients diagnosed in the early stages respond better to treatment and maintain functional capacity longer.

Delayed diagnosis often means significant, irreversible heart damage has already occurred. Once the heart becomes severely stiffened, even the best treatments have limited effectiveness.

Early treatment also prevents unnecessary procedures and medications. Patients sometimes undergo invasive heart procedures or take medications with side effects when their true condition goes unrecognized.

Awareness of ATTR-CM continues to grow among healthcare providers. As more doctors learn to recognize the condition, diagnosis rates are improving and patients are getting appropriate care sooner.